FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2189898826> ?p ?o ?g. }

• W2189898826 endingPage "44" @default.
• W2189898826 startingPage "37" @default.
• W2189898826 abstract "In this study, we tested the effectiveness of a melanoma-associated antigen-derived peptide, MART-1(27-35), in eliciting cellular immune responses in vivo in the context of a phase I active immunization protocol. This peptide (AAGIGILTV) corresponds to residues 27-35 from the nonmutated melanoma-associated antigen MART-1/Melan A and is recognized by most melanoma-specific, HLA-A*0201-restricted, tumor-infiltrating lymphocytes. To test the in vivo induction of cytotoxic T lymphocyte (CTL) sensitization, we compared CTL reactivity in vitro from peripheral blood mononuclear cell (PBMC) pools obtained before and after vaccination.MART-1(27-35) was administered to HLA-A*0201 melanoma patients subcutaneously in an emulsification with incomplete Freund's adjuvant. A vaccination course included four inoculations of peptide at 3-week intervals. PBMC collected by leukapheresis and separated by Ficoll-Hypaque gradient before and after vaccination were analyzed in 18 patients by in vitro sensitization with MART-1(27-35). To induce MART-1(27-35)-specific CTL, PBMC were incubated with 1 microM peptide (on day 0) and interleukin-2 (IL-2) (300 IU/mL, on days 1 and 4 after each stimulation). At weekly intervals, cells were harvested and an aliquot was cryopreserved for later analysis. The remaining cells were replated and restimulated using irradiated autologous PBMC pulsed with 1 microM of relevant peptide. After three restimulations, all samples from one patient were tested simultaneously for HLA-A*0201-restricted anti-MART-1(27-35) reactivity by microcytotoxicity and cytokine (IFN-gamma) release assays.Toxicities were minimal and consisted of local irritation at the site of vaccine administration. None of the patients sustained a clinical response. The first eight patients were monitored by inducing CTL reactivity from PBMC obtained preimmunization and after two and four vaccinations. Only two prevaccination cultures were reactive to MART-1, compared with five and seven cultures from PBMC obtained after two and four vaccinations, respectively. Thus, an enhancement in cytotoxic activity could be detected in postvaccination CTL cultures, and serial vaccine administrations appeared to boost the detectability of cytotoxicity in vitro. For completeness, the analysis compared prevaccination with postvaccination PBMC cultures. Specific anti-MART-1(27-35) cytotoxicity (> or = 10 lytic units) could be detected in two prevaccination and 12 postvaccination cultures after two in vitro stimulations. In 15 postvaccination CTL cultures, a more than threefold increase in specific release of IFN-gamma was noted, compared with prevaccination.In vivo administration of a melanoma-associated antigen peptide, emulsified in incomplete Freund's adjuvant, could safely augment CTL reactivity against epitopes commonly expressed by melanoma cells. Although the enhancement of CTL reactivity did not achieve tumor regression, it is possible that the use of recombinant immunogens with increased immunomodulatory capabilities in future clinical trials could reach the threshold of CTL activation necessary for tumor regression." @default.
• W2189898826 created "2016-06-24" @default.
• W2189898826 creator A5001407294 @default.
• W2189898826 creator A5007797886 @default.
• W2189898826 creator A5036547243 @default.
• W2189898826 creator A5059941996 @default.
• W2189898826 creator A5063052853 @default.
• W2189898826 creator A5069765350 @default.
• W2189898826 creator A5072133376 @default.
• W2189898826 creator A5085899790 @default.
• W2189898826 date "1997-01-01" @default.
• W2189898826 modified "2023-10-17" @default.
• W2189898826 title "Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A." @default.
• W2189898826 cites W1531422989 @default.
• W2189898826 cites W1536271706 @default.
• W2189898826 cites W1562228673 @default.
• W2189898826 cites W1575119798 @default.
• W2189898826 cites W1621302028 @default.
• W2189898826 cites W1898024522 @default.
• W2189898826 cites W1932934724 @default.
• W2189898826 cites W1986046751 @default.
• W2189898826 cites W1992847016 @default.
• W2189898826 cites W2007038853 @default.
• W2189898826 cites W2018227907 @default.
• W2189898826 cites W2037260212 @default.
• W2189898826 cites W2037387436 @default.
• W2189898826 cites W2041679777 @default.
• W2189898826 cites W2045642969 @default.
• W2189898826 cites W2051221638 @default.
• W2189898826 cites W2114657480 @default.
• W2189898826 cites W2115160431 @default.
• W2189898826 cites W2130185552 @default.
• W2189898826 cites W2144761873 @default.
• W2189898826 cites W2146600597 @default.
• W2189898826 cites W2149940155 @default.
• W2189898826 cites W2152921605 @default.
• W2189898826 cites W2410443354 @default.
• W2189898826 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2597550" @default.
• W2189898826 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9072306" @default.
• W2189898826 hasPublicationYear "1997" @default.
• W2189898826 type Work @default.
• W2189898826 sameAs 2189898826 @default.
• W2189898826 citedByCount "87" @default.
• W2189898826 countsByYear W21898988262013 @default.
• W2189898826 countsByYear W21898988262015 @default.
• W2189898826 countsByYear W21898988262016 @default.
• W2189898826 countsByYear W21898988262017 @default.
• W2189898826 countsByYear W21898988262018 @default.
• W2189898826 countsByYear W21898988262021 @default.
• W2189898826 countsByYear W21898988262022 @default.
• W2189898826 crossrefType "journal-article" @default.
• W2189898826 hasAuthorship W2189898826A5001407294 @default.
• W2189898826 hasAuthorship W2189898826A5007797886 @default.
• W2189898826 hasAuthorship W2189898826A5036547243 @default.
• W2189898826 hasAuthorship W2189898826A5059941996 @default.
• W2189898826 hasAuthorship W2189898826A5063052853 @default.
• W2189898826 hasAuthorship W2189898826A5069765350 @default.
• W2189898826 hasAuthorship W2189898826A5072133376 @default.
• W2189898826 hasAuthorship W2189898826A5085899790 @default.
• W2189898826 hasConcept C137061746 @default.
• W2189898826 hasConcept C147483822 @default.
• W2189898826 hasConcept C147969180 @default.
• W2189898826 hasConcept C154317977 @default.
• W2189898826 hasConcept C167672396 @default.
• W2189898826 hasConcept C202751555 @default.
• W2189898826 hasConcept C203014093 @default.
• W2189898826 hasConcept C2776090121 @default.
• W2189898826 hasConcept C2777658100 @default.
• W2189898826 hasConcept C2779053233 @default.
• W2189898826 hasConcept C502942594 @default.
• W2189898826 hasConcept C55493867 @default.
• W2189898826 hasConcept C71924100 @default.
• W2189898826 hasConcept C86803240 @default.
• W2189898826 hasConcept C8891405 @default.
• W2189898826 hasConceptScore W2189898826C137061746 @default.
• W2189898826 hasConceptScore W2189898826C147483822 @default.
• W2189898826 hasConceptScore W2189898826C147969180 @default.
• W2189898826 hasConceptScore W2189898826C154317977 @default.
• W2189898826 hasConceptScore W2189898826C167672396 @default.
• W2189898826 hasConceptScore W2189898826C202751555 @default.
• W2189898826 hasConceptScore W2189898826C203014093 @default.
• W2189898826 hasConceptScore W2189898826C2776090121 @default.
• W2189898826 hasConceptScore W2189898826C2777658100 @default.
• W2189898826 hasConceptScore W2189898826C2779053233 @default.
• W2189898826 hasConceptScore W2189898826C502942594 @default.
• W2189898826 hasConceptScore W2189898826C55493867 @default.
• W2189898826 hasConceptScore W2189898826C71924100 @default.
• W2189898826 hasConceptScore W2189898826C86803240 @default.
• W2189898826 hasConceptScore W2189898826C8891405 @default.
• W2189898826 hasIssue "1" @default.
• W2189898826 hasLocation W21898988261 @default.
• W2189898826 hasOpenAccess W2189898826 @default.
• W2189898826 hasPrimaryLocation W21898988261 @default.
• W2189898826 hasRelatedWork W141088424 @default.
• W2189898826 hasRelatedWork W1970289093 @default.
• W2189898826 hasRelatedWork W1977726640 @default.
• W2189898826 hasRelatedWork W2034633641 @default.
• W2189898826 hasRelatedWork W2111460888 @default.

• next